EZH2 and cervical carcinoma: In addition, the immunochemical staining of cervical cancer tissues performed in this study revealed that EZH2 expression was positively correlated with the expression of target genes in the Wnt/β-catenin pathway and that it was negatively correlated with its inhibitors, GSK-3β and TP53 (Figure 6).